Global Footprint, Single Focus
The Trout Group is the leading global investor relations and strategic advisory firm servicing the life sciences industry. Since 1996, the firm has been providing companies with expert counsel and access to the institutional investment community.
With two decades of experience in the biotechnology, pharmaceutical, medical technology and life science technology sectors, the Trout Group offers its clients the knowledge base needed to clarify investment themes and leverage key relationships for increased exposure to the proper audience. The firm’s global reach extends through a network of offices in New York, Boston, San Francisco, and London with contacts in all major financial centers, helping clients to connect with the right investors.
Active, Senior-Level Support
Our highly qualified team offers a global, multidisciplinary approach to investor relations and strategic planning. Our senior-level support is an essential component of our team structure, and we are available to clients on a 24/7 basis. We collaborate with our clients to deliver tailored solutions designed to yield strong investor relationships. Our industry-specific experience and expertise enable us to look beyond standard solutions to increase our clients' access, appeal, and visibility within the investor community.
Our ability to navigate the complex channels of the global investment community increases the likelihood of finding those most receptive to our clients' stories. Our suite of services centers on an active investor relations program, combined with access to the investment community including:
- Institutional investors well matched to our clients’ industry segment, size and stage of development
- Sell-side analysts who cover companies in our clients’ product areas or market cap range
- Investment bankers who can work with our clients towards various financial goals
- Select high-volume brokers who trade in these sectors and can potentially add volume and stability to a stock